Northrop Grumman (NOC) Q3 2025 10-Q Quarterly Report
Filed: Oct 21, 2025Period ending Sep 30, 2025
Health Care
Search, Detection, Navigation, Guidance, Aeronautical SysSEC EDGAR Northrop Grumman (NOC) 10-Q quarterly report for Q3 2025, filed with SEC EDGAR on Oct 21, 2025 for the fiscal period ending Sep 30, 2025. This page provides AI-powered analysis including management discussion & analysis (MD&A), risk factor updates, and key quarterly financial data such as revenue and net income extracted from XBRL.
Northrop Grumman Q3 2025 10-Q Analysis
Management Discussion & Analysis
- • Revenue $10.4B Q3 2025, up 4% YoY from $10.0B, driven by Mission Systems, Defense Systems, Aeronautics; Space Systems declined 6%
- • Operating margin 11.9% Q3 2025 vs 11.2% Q3 2024; YTD margin 10.7% vs 10.8% YoY, impacted by B-21 loss provision and divestiture gain
- • Best segment Q3: Defense Systems sales up 14% to $2.06B, margin 11.4% vs 8.9% YoY; Worst segment: Space Systems sales down 6% to $2.7B, margin 11.0% vs 12.0%
- • Cash $2.0B at Sept 2025; operating cash flow down 52% YTD to $1.81B due to $1.0B higher taxes and working capital timing; free cash flow down 92%
- • Near-term headwinds: ongoing US government shutdown risk, B-21 program cost challenges ($477M loss provision in Q1 2025), and macroeconomic and regulatory uncertainties
Risk Factors
- • No material changes in risk factors from 2024 10-K reported in this 10-Q filing
Northrop Grumman Q3 2025 Quarterly FinancialsXBRL
Revenue
$10.4B
▲ +4.3% YoY▲ +0.7% QoQ
Net Income
$1.1B
▲ +7.2% YoY▼ -6.3% QoQ
Operating Margin
11.9%
▲ +71bp YoY▼ -185bp QoQ
Net Margin
10.6%
▲ +29bp YoY▼ -79bp QoQ
ROE
6.9%
Total Assets
$49.3B
EPS (Diluted)
$7.67
▲ +9.6% YoY▼ -5.7% QoQ
Operating Cash Flow
$1.6B
▲ +42.7% YoY▲ +79.4% QoQ
Source: XBRL data from Northrop Grumman Q3 2025 10-Q filing on SEC EDGAR. All figures in USD.
Get deeper insights on Northrop Grumman
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.